Therapy development for cancer and cardiovascular disease (CVD) to prolong lifespan makes the relationship between these two conditions more complex. Drug interactions in cardiology and oncology are associated with metabolism and drug transportation. Advances in biomarkers and imaging provide novel methods for detecting cardiotoxicity, including cardiac injury and inflammation. The new concept of CVD-related cancer risk is leading to a new direction of progression termed "reverse cardio-oncology."
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10846296 | PMC |
| http://dx.doi.org/10.1016/j.cpt.2023.02.002 | DOI Listing |
Publication Analysis
Top Keywords
evolving field
4
field cardio-oncology
4
cardio-oncology therapy
4
therapy development
4
development cancer
4
cancer cardiovascular
4
cardiovascular disease
4
disease cvd
4
cvd prolong
4
prolong lifespan
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!